AA
COLL icon

ALPS Advisors’s Collegium Pharmaceutical COLL Stock Holding History

ALPS Advisors’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$475K Buy
+14,350
New +$608K ﹤0.01% 903
2025
Q1 		– Sell
-9,454
Closed -$271K – 1025
2024
Q4 		$271K Sell
9,454
-200
-2% -$6.62K ﹤0.01% 948
2024
Q3 		$373K Buy
9,654
+439
+5% +$15.7K ﹤0.01% 726
2024
Q2 		$297K Sell
9,215
-55
-0.6% -$1.91K ﹤0.01% 851
2024
Q1 		$360K Buy
+9,270
New +$324K ﹤0.01% 767
2019
Q3 		– Sell
-22,320
Closed -$294K – 855
2019
Q2 		$294K Sell
22,320
-1,176
-5% -$15.7K ﹤0.01% 844
2019
Q1 		$356K Buy
+23,496
New +$376K ﹤0.01% 852

Other funds holding COLL

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return